OneMedNet Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-23.21	-23.21	-6.23	-2.94
Depreciation & Amortization	0.03	0.03	0.02	0.01
Share-Based Compensation	0	0	1.6	0.1
Other Operating Activities	31.4	31.4	91.84	0.98
Operating Cash Flow	8.22	8.22	87.24	-1.84
Operating Cash Flow Growth	-90.58%	-90.58%	-	-
Capital Expenditures	-0.04	-0.04	-0.06	-0.03
Investing Cash Flow	-0.04	-0.04	-0.06	-0.03
Share Issuance / Repurchase	-10.56	-10.56	-85.72	0
Debt Issued / Paid	-8.67	-8.67	5.54	2.49
Other Financing Activities	10.79	10.79	-7.85	-
Financing Cash Flow	-8.43	-8.43	-88.03	2.49
Net Cash Flow	-0.25	-0.25	-0.85	-0.62
Free Cash Flow	8.18	8.18	87.18	-1.87
Free Cash Flow Growth	-90.62%	-90.62%	-	-
Free Cash Flow Margin	800.39%	800.39%	7562.99%	-171.68%
Free Cash Flow Per Share	0.35	0.35	7.19	-0.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).